back to
back to

Program: Sunday (13.10.2013)

07:30 – 08:30

Room: Großer Saal

Satellite Symposium Novel Methodology to aid in the Diagnosis of Difficult Hodgkin Lymphoma Cases

  • Volker Diehl

  • Introduction and Perspective

    • Volker Diehl

  • Novel methodology to aid in the diagnosis of di cult lymphoma cases

    • Lawrence Weiss

  • Case Series Presentation using MultiOmyx Methodology

    • Lawrence Weiss

  • Questions & Answers

08:30 – 10:00

Room: Großer Saal

Scientific Session Interactive Case Discussions

  • Peter Borchmann
  • Patrice Carde
  • Jonathan Friedberg
  • Richard Hoppe

10:30 – 12:00

Room: Großer Saal

Scientific Session Pathways

  • Margaret Shipp
  • Anke van den Berg

  • JAK / STAT

    • Margaret Shipp

  • Non-coding RNA and tumor cell survival

    • Anke van den Berg

  • CSF1 and CSF1R

    • Stephan Mathas

  • Integrated genomic analysis of ow sorted Hodgkin and Reed-Sternberg cell in primary classical Hodgkin Lymphoma

    • Jonathan Reichel

  • TCF3 / E2A (19p13.3) is a novel Hodgkin Lymphoma susceptibility locus; a meta-GWAS study from the InterLymph Hodgkin Lymphoma consortium

    • Anke van den Berg

  • Hodgkin-Reed-Sternberg cells in classical Hodgkin Lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity

    • Maciej Giefing

12:15 – 13:45

Room: Großer Saal

Satellite Symposium Lenalidomide in Lymphoma – Latest Update on Clinical Data

  • Andreas Engert

  • Rationale and Clinical Experience with Lenalidomide in Hodgkin Lymphoma

    • Boris Böll

  • Progress in the treatment of Aggressive B-Cell Lymphomas

    • Grzegorz S. Nowakowski

  • Emerging treatment options for mantle cell lymphoma

    • Pier Luigi Zinzani

14:00 – 15:15

Room: Großer Saal

Satellite Symposium New Insights in the Treatment and Management of Lymphoid Malignancies

  • Ruth Pettengell

  • New Aspects on Dose Density in Malignant Lymphoma

    • Ruth Pettengell

  • The impact of hematological toxicity in Hodgkin Lymphoma

    • Peter Borchmann

  • Bispeci c CD19 antibodies – a new treatment principle for management of relapsed / refractory ALL and NHL

    • Nicola Gökbuget

16:00 – 17:30

Room: Großer Saal

Satellite Symposium Relapsed/Refractory Hodgkin Lymphoma: Exploring Targeted Therapeutic Options

  • Andreas Engert

  • Welcome and Introduction

    • Andreas Engert

  • The challenge of relapsed Hodgkin Lymphoma in the era of contemporary therapy

    • Andreas Engert

  • Q&A

  • Defining the ideal target in Hodgkin Lymphoma

    • Stefano Pileri

  • Q&A

  • Targeting CD30 with monoclonal antibody- based constructs

    • Anas Younes

  • Q&A

  • Current success and future opportunities with targeted therapy in Hodgkin Lymphoma

    • Sven Borchmann

  • Q&A

  • Closing comments

    • Andreas Engert

18:00 – 20:00

Room: Großer Saal

Main Program Opening Ceremony

  • Bonadonna Lecture: The Hodgkin puzzle: Are we getting close?

    • Klaus Rajewsky

  • Awards Ceremony

20:00

Room: Weinkeller

Main Program Get Together

Archive

You a viewing the program of a past symposium. Click here to get back to the current conference.